fondaparinux and per-6-amino-beta-cyclodextrin

fondaparinux has been researched along with per-6-amino-beta-cyclodextrin* in 1 studies

Other Studies

1 other study(ies) available for fondaparinux and per-6-amino-beta-cyclodextrin

Article	Year
Structural characterization of fondaparinux interaction with per-6-amino-beta-cyclodextrin: An NMR and MS study. Journal of pharmaceutical and biomedical analysis, 2021, Apr-15, Volume: 197 The highly anionic synthetic pentasaccharide fondaparinux (FDPX) - representing the antithrombin binding sequence of heparin - is in clinical use as a potent anticoagulant. Contrary to the unfractionated heparin, FDPX lacks potent antidote completely reversing its anticoagulant activity, therefore it is of great importance to identify new structures exhibiting strong intermolecular interactions towards FDPX. The polycationic heptakis(6-amino-6-deoxy)-beta-cyclodextrin (NH Topics: beta-Cyclodextrins; Fondaparinux; Heparin; Magnetic Resonance Spectroscopy	2021

Article

Year

Structural characterization of fondaparinux interaction with per-6-amino-beta-cyclodextrin: An NMR and MS study.

Journal of pharmaceutical and biomedical analysis, 2021, Apr-15, Volume: 197

The highly anionic synthetic pentasaccharide fondaparinux (FDPX) - representing the antithrombin binding sequence of heparin - is in clinical use as a potent anticoagulant. Contrary to the unfractionated heparin, FDPX lacks potent antidote completely reversing its anticoagulant activity, therefore it is of great importance to identify new structures exhibiting strong intermolecular interactions towards FDPX. The polycationic heptakis(6-amino-6-deoxy)-beta-cyclodextrin (NH

Topics: beta-Cyclodextrins; Fondaparinux; Heparin; Magnetic Resonance Spectroscopy

2021